Lebrikizumab Treatment in Adults with AsthmaSurs W
Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365(12):1088-1098. doi:10.1056/NEJMoa1106469 PubMedGoogle ScholarCrossref 43. Hanania NA, Noonan M, Corren J, et al. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-...
Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011 Sep 22;365(12):1088-98. 品牌介绍:• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;• ...
Lebrikizumab is an IgG4 humanized monoclonal antibody that specifically binds tointerleukin-13 (IL-13)and inhibits its function. Lebrikizumab can be used for the research of asthma[1]. [1]. Jonathan Corren, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011 Sep 22;365...
Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011 Sep 22;365(12):1088-98. 品牌介绍:• MCE (MedChemExpress) 拥有200 多种全球独家化合物,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;• 设...
Of these drugs, only mepolizumab, reslizumab, benralizumab, and dupilumab have been FDA-approved for the treatment of severe asthma. Of note, dupilumab has also been approved for the treatment of atopic dermatitis/eczema in adults. The benefits of new monoclonals are the excellent safety ...
Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic study. Ann Allergy Asthma Immunol. 2021;126(4):417-428. xvii Munera-Campos M, et al. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment. Actas Dermosifilio...
The safety profile for lebrikizumab consisted of adverse events that were mostly nonserious, mild or moderate in severity, and did not lead to stopping treatment. The safety profile was similar in both adults and adolescents. Digital Features for this article can be found at https://doi....
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657-682. doi:10.1111/jdv.14891PubMedGoogle ScholarCrossref 16. Wollenberg A, Barbarot S, Bieber T, et al; ...
Therapeutic potential of lebrikizumab in the treatment of atopic dermatitis. J Asthma Allergy. 2020;13:109–114. doi: 10.2147/JAA.S211032. (Open in a new window)PubMed (Open in a new window)Web of Science ®(Open in a new window)Google Scholar Bieber T. Interleukin-13: targeting an...